Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Short-term Investments (2022 - 2024)

Oncology Institute's Short-term Investments history spans 3 years, with the latest figure at $9.9 million for Q2 2024.

  • For Q2 2024, Short-term Investments fell 3.42% year-over-year to $9.9 million; the TTM value through Jun 2024 reached $9.9 million, down 3.42%, while the annual FY2023 figure was $49.4 million, 17.44% down from the prior year.
  • Short-term Investments reached $9.9 million in Q2 2024 per TOI's latest filing, down from $29.8 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $59.9 million in Q3 2023 to a low of $9.9 million in Q2 2024.
  • Average Short-term Investments over 3 years is $36.0 million, with a median of $35.0 million recorded in 2023.
  • Peak YoY movement for Short-term Investments: surged 105.38% in 2023, then fell 25.8% in 2024.
  • A 3-year view of Short-term Investments shows it stood at $59.8 million in 2022, then decreased by 17.44% to $49.4 million in 2023, then crashed by 79.87% to $9.9 million in 2024.
  • Per Business Quant, the three most recent readings for TOI's Short-term Investments are $9.9 million (Q2 2024), $29.8 million (Q1 2024), and $49.4 million (Q4 2023).